DIRS.INFO The most relevant business & tech news

☆ Coherus BioSciences launches biosimilar version of AbbVie's blockbuster Humira
▼ + stars: | 2023-07-03 | by ( ) www.reuters.com time to read: +1 min

July 3 (Reuters) - Coherus BioSciences (CHRS.O) said on Monday it has launched a copycat version of AbbVie's (ABBV.N) Humira in the United States at a discount of more than 85% to the blockbuster arthritis drug. Coherus is the latest to launch a biosimilar to Humira in the U.S. market this month after Boehringer Ingelheim, Sandoz and Organon (OGN.N). Coherus said last month it would sell the biosimilar, branded as Yusimry, at $995 per carton, compared with the current list price of Humira of $6,922 per carton. The company has also partnered with billionaire entrepreneur Mark Cuban's pharmaceutical startup to sell the biosimilar at $569.27 plus dispensing and shipping fees. Usually prices fall, often dramatically, when multiple copycat versions of a widely-used medication enter the market.

Persons: Coherus, Boehringer Ingelheim, Mark, Sriparna Roy, Leroy Leo, Shounak Dasgupta, Arun Koyyur Organizations: Coherus BioSciences, Sandoz, Thomson Locations: United States, Humira, U.S, Organon, Bengaluru

☆ Barbara Corcoran says 90% of her 'Shark Tank' investments don't make her money—here's why she doesn't regret any of them
▼ + stars: | 2023-05-09 | by ( Megan Sauer | ) www.cnbc.com time to read: +2 min

Barbara Corcoran doesn't want to hear your startup pitches outside of ABC's "Shark Tank." Rather, it's because only one in every 10 of her "Shark Tank" investments actually earns a profit, she said. Because of the high-risk nature of investing, the 74-year-old said she only pulls out her wallet for a select few "Shark Tank" pitches. She's not the only "Shark Tank" investor who feels that way. Disclosure: CNBC owns the exclusive off-network cable rights to "Shark Tank."

☆ NBA fines Mark Cuban's Mavericks $750K for tanking key game
▼ + stars: | 2023-04-14 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNBA fines Mark Cuban's Mavericks $750K for tanking key gameHosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m. ET on CNBC. Shams Charania, Fan Duel TV's "Run It Back" co-host, joins the show to discuss the NBA fine against the Mavericks.

☆ Billionaire Mark Cuban invested in digital-health's go-to pharmacy even though it struggled to keep up with orders from his drug-pricing company
▼ + stars: | 2023-01-25 | by ( Blake Dodge | ) www.businessinsider.com time to read: +3 min

Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021. When asked about the delays, Cuban said Cost Plus Drugs' volume exceeded both companies' expectations.

☆ Pharma CEOs say Mark Cuban's effort to upend the drug industry is 'a really great idea' but will be difficult to pull off
▼ + stars: | 2023-01-25 | by ( Yeji Jesse Lee | Andrew Dunn | ) www.businessinsider.com time to read: +7 min

Biopharma CEOs say his company Cost Plus Drugs could remove costs from the distribution system. Cuban told Insider in an email that he believed the company's pricing transparency was "an absolute positive for patients." The company started its pharmacy services last year and quickly racked up over 1 million accounts, Cuban told Insider recently. Cost Plus Drugs is focused on bringing down the price of generic medications, which no longer have patent protections but can still be expensive. Cuban told Insider that EQRx was in a "different business" than what he's attempting to build out.

☆ Billionaire Mark Cuban has invested in yet another healthcare company: online pharmacy Truepill
▼ + stars: | 2023-01-20 | by ( Blake Dodge | ) www.businessinsider.com time to read: +3 min

Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. Truepill works with healthcare startups to send medications through the mail. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021.

☆ Mark Cuban: ‘People thought I was an idiot’ for launching the company I sold for billions
▼ + stars: | 2023-01-15 | by ( Tom Huddleston Jr. | ) www.cnbc.com time to read: +3 min

Take Broadcast.com, the pioneering audiov streaming company that made Mark Cuban a billionaire. In 1995, Cuban was living off of the roughly $2 million in proceeds from the sale of his first tech company, MicroSolutions. But it was great timing for Cuban, who sold most of his stock before the market crashed. "[It's] the origin story of streaming," Cuban told CBS. I'll just turn on the radio,'" Cuban said on a 2021 episode of the "Starting Greatness" podcast.

☆ Mark Cuban's pharmaceuticals startup ties up with RxPreferred
▼ + stars: | 2023-01-11 | by ( ) www.reuters.com time to read: +1 min

Jan 11 (Reuters) - Billionaire entrepreneur Mark Cuban's pharmaceuticals startup has tied up with pharmacy benefits manager RxPreferred Benefits, the companies said on Wednesday, in a move to offer lower priced drugs through some employer-backed health insurance plans. Mark Cuban Cost Plus Drugs provides generic drugs through direct contracts with manufacturers and charges a standard markup on every drug it sells. Under the partnership, RxPreferred Benefits' customers will have the option to use Mark Cuban Cost Plus Drugs as part of their health insurance plans. Mark Cuban Cost Plus Drugs in December partnered with EmsanaRx, a nonprofit coalition of nearly 40 companies including U.S. retailers Walmart (WMT.N) and Costco (COST.O), that operates a PBM service for employers. PBMs serve as intermediaries between drug manufacturers, health insurance plans and pharmacies to negotiate prescription drug prices.

☆ Mark Cuban tells Elon Musk 'your business, your decision' after his suggestion that only certain users should pay the $8 verification fee was bluntly rejected
▼ + stars: | 2022-11-07 | by ( Kate Duffy | ) www.businessinsider.com time to read: +2 min

Mark Cuban told Elon Musk that Twitter was "his business," following an exchange between the pair. Elon Musk replied to Cuban, saying: "$8 for all." Cuban wrote in the tweet. Musk replied to Cuban, saying: "$8 for all." Your decision," Cuban wrote in a quote-tweet to Musk.

☆ Mark Cuban says this is 'one of the worst traits' he's ever seen in a 'Shark Tank' contestant
▼ + stars: | 2022-10-25 | by ( Megan Sauer | ) www.cnbc.com time to read: +2 min

On Friday's episode of ABC's "Shark Tank," the billionaire investor highlighted one startup founder as an example of the latter category. "One of the great traits of any good entrepreneur is resilience, and you've certainly shown that," Cuban told Amy Leinbach, the founder of children's tool company Big Bee, Little Bee. The Huntington Beach, California-based company is known for the ScrubBee, a handheld silicone scrubber that brought in 80% of Big Bee, Little Bee's sales last year. Leinbach asked the Sharks for $100,000, in exchange for a 20% stake in Big Bee, Little Bee. At the time of taping, she said she had already invested $100,000 of her own money to build "Marker Parker."

☆ 20-year-old who tracks Elon Musk and Mark Zuckerberg's private jets says Facebook took down his page because it violates their policy
▼ + stars: | 2022-09-23 | by ( Grace Kay | ) www.businessinsider.com time to read: +3 min

Jack Sweeney said Facebook shut down his page that tracks Elon Musk's jets. "Really @Facebook," Sweeney tweeted. The billionaire told Sweeney he was concerned for his safety and didn't "love the idea of being shot by a nutcase." Sweeney previously told Insider that he countered Musk's offer, asking for $50,000 instead, but Musk declined. Earlier this year, he told Insider he stopped tracking Mark Cuban's jets on Twitter after the billionaire investor reached out and offered him business advice in exchange.

☆ Mark Cuban’s pharmacy startup is actually making drugs less expensive. It's still working on solving the real problem
▼ + stars: | 2022-07-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Imatinib, a leukemia medication with a retail price of more than $2,500, is just $14.40 at Cost Plus Drugs. But experts say that Cost Plus Drugs' impact is limited, at least for now, because it hasn't broken into the market driving those exorbitant prices: brand-name drugs. Instead of negotiating prices through those pharmacy benefit managers, Cost Plus Drugs directly negotiates with manufacturers to get generic drugs at wholesale prices. The trade-off: Cost Plus Drugs doesn't accept insurance claims, since insurers don't typically work with pharmacies that avoid pharmacy benefit managers. That gives drugmakers little-to-no incentive to offer rebates to Cost Plus Drugs, Hernandez notes.

☆ Mark Cuban took a trip to celebrate selling his company for $5.7 billion – and ended up in coach in a middle seat
▼ + stars: | 2021-12-24 | by ( Nicolas Vega | ) www.cnbc.com time to read: +2 min

Selling a company for billions of dollars didn't immediately upgrade Mark Cuban's life. "When I sold my company for billions of dollars, to go and celebrate, I was on a Southwest flight," Cuban told ABC News earlier this year. In 1999, Cuban and his Broadcast.com co-founders sold their company to Yahoo for $5.7 billion in stock. "That served me a long, long time." Buying a private jet "was my all-time goal," Cuban told Money in 2017.

Search resuls for: "Mark Cuban's"

13 mentions found